logo
Select company
Select metric
$ -244.78MConsolidated Income
VS
Market
5
Sector
8
Industry
10
History
-
$ 9.84Close
$ 8.24 - $ 28.14 52-Week Range
Ticker Information

Ticker

NRIX

Company Name

NURIX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NURIX THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRIX - Cons. Inc. Historical data
DateConsolidated Income
9/30/2025$ -244.78M
6/30/2025$ -207.32M
3/31/2025$ -208.4M
12/31/2024$ -193.57M
9/30/2024$ -176.98M
6/30/2024$ -165M
3/31/2024$ -144.73M
12/31/2023$ -143.95M
9/30/2023$ -148.71M
6/30/2023$ -157.44M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NURIX THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -43.24M.
  • Over the past 5 years, NURIX THERAPEUTICS INC's average Cons. Inc. has been $ -155.79M.
  • The median Cons. Inc. for NURIX THERAPEUTICS INC during this period was $ -157.44M
  • NURIX THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -43.24M.
  • The lowest Cons. Inc. recorded by NURIX THERAPEUTICS INC in the same timeframe $ -244.78M

NURIX THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
SNDX : SYNDAX PHARMACEUTICALS INC $ -334.99MURGN : UROGEN PHARMA LTD $ -154.97MTBPH : THERAVANCE BIOPHARMA INC $ 13.03MKURA : KURA ONCOLOGY INC $ -197.17MGYRE : GYRE THERAPEUTICS INC $ 8.73MZVRA : ZEVRA THERAPEUTICS INC $ 2.64MCRMD : CORMEDIX INC $ 51.16MNAGE : NIAGEN BIOSCIENCE INC $ 17.73MSAGE : SAGE THERAPEUTICS INC $ -301.19MEYPT : EYEPOINT PHARMACEUTICALS INC $ -175.38M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

NRIX - Consolidated Income, Last 5 years

$ -244.78M

Minimum

Sep 30, 2025

$ -43.24M

Maximum

Dec 31, 2020

$ -155.79M

Average

$ -157.44M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M